Sinopharm Group Co. Ltd.

SHTDY · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$3,458$3,346$3,704$4,949
Dep. & Amort.$2,233$2,404$2,330$2,310
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0$61,369-$61,369$61,205
Other Non-Cash-$39,802-$14,579$14,342-$7,965
Operating Cash Flow-$34,111$52,540-$40,994$60,499
Investing Activities
PP&E Inv.-$671-$1,438-$1,023-$660
Net Acquisitions$0$102-$102$43
Inv. Purchases$0$0$0$62
Inv. Sales/Matur.$0$0$0-$150
Other Inv. Act.$139-$1,377$87-$251
Investing Cash Flow-$531-$2,712-$1,039-$957
Financing Activities
Debt Repay.$18,714$0$23,869-$25,180
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$2,143-$2,715-$2,340-$2,559
Other Fin. Act.-$991-$36,122$23-$1,202
Financing Cash Flow$15,579-$38,837$21,552-$28,940
Forex Effect-$12-$9$4-$3
Net Chg. in Cash$35,238-$43,332$43,332$30,548
Supplemental Information
Beg. Cash$0$43,332$0$33,260
End Cash$35,238$54,313$43,332$63,809
Free Cash Flow-$34,782$51,102-$42,017$59,259
Sinopharm Group Co. Ltd. (SHTDY) Financial Statements & Key Stats | AlphaPilot